Health Care · Services-Home Health Care Services

ADUS Addus HomeCare Corp SEC Filings & Insider Trading Activity 2026

company
CIK 1468328133 filings
Russell 2000

ADUS at a glance

Addus HomeCare Corp (ADUS, SEC CIK 1468328) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as November 16, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Addus HomeCare Corp (ADUS) reported revenue of $1.4 billion (up 23.2% from FY2024) and net income of $95.9 million. Diluted EPS was $5.22.
  • As of September 30, 2026, 31 institutional investment managers tracked by SignalX reported holding Addus HomeCare Corp (ADUS) shares worth $992.3 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by BLESSING CLIFF DONALD on November 10, 2026 of 893 shares at $123.10 per share.
  • In the last 90 days, ADUS insiders reported 0 open-market purchases ($0) and 22 open-market sales ($17.5M) on Form 4, a net sale of $17.5M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$1.4B
+23.2% vs prior year
Insiders · 90 days
0 buys · 22 sells
Net −$17.5M
13F holders
31 funds
$992.3M · +0 vs prior quarter
Latest 8-K
Nov 3, 2026
Item 2.02 · Item 7.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business: Home-based care services including personal care, hospice, and home health primarily for dual-eligible Medicare and Medicaid consumers
  • New emphasis: Expansion of clinical care services and full integration of personal care, hospice, and home health in Ohio, Tennessee, Illinois, and New Mexico
  • Strategic shift: Increased focus on partnering with managed care organizations amid shift from fee-for-service to managed care models with narrower networks
  • Quantitative highlight: Net service revenue $1.423B in 2025, up 23% from $1.155B in 2024; served ~107,000 consumers through 262 offices in 23 states
  • Noteworthy fact: Completed four acquisitions in 2025 adding $11.8M revenue, shifting toward market expansion targeting fiscally managed states with favorable minimum wage environments

Risk Factors

  • Variable interest rates on $124.3 million revolving loan with $8.5 million interest payable within 12 months at 5.48% as of January 2026
  • Inflation-driven wage increases impacting caregiver labor costs amid tight labor market and limited fee rate increases from government programs
  • Fixed lease obligations totaling $59.5 million, with $15.8 million payable within 12 months affecting cash flow and operational flexibility

Management Discussion & Analysis

  • Revenue $1.423B in 2025, up 23.2% YoY from $1.155B in 2024; personal care +$232.6M, hospice +$34.4M, home health +$0.9M
  • Operating margin 9.7% in 2025 vs 8.9% in 2024; gross margin steady at 32.5% both years
  • Best performing segment: personal care revenue +27.2% to $1.089B; worst: home health +1.3% to $70.8M
  • Net income $95.9M (6.7% margin), up 30.3% from $73.6M (6.4% margin) in 2024
  • Interest expense $13.6M vs $7.7M (borrowings increase); income tax rate 24.7% vs 25.9%
  • Capital allocation includes acquisitions totaling ~$385.8M (Gentiva $353.6M, Helping Hands $21.4M, others); no cash flow, buyback or dividend details disclosed
  • Management highlights reimbursement rate increases in Illinois and Texas for 2026; notes risks from Medicaid funding changes and regulatory uncertainties
  • Gain on New York divestiture $3.7M recorded in 2024; no similar gains in 2025

AI summary of the ADUS 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • New acquisition risk: AccentCare personal care division purchase, approximately $275.0 million, requires regulatory approvals
  • Transaction risk: Acquisition may fail or face delays, while transaction costs remain payable regardless of closing
  • Integration risk: Unanticipated liabilities, regulatory risks, and expenses could offset anticipated AccentCare benefits
  • Operational risk: Management resources diverted to the acquisition, potentially weakening existing operations
  • Market risk: Investor concerns about AccentCare could reduce Addus common stock price

Management Discussion & Analysis

  • Quarterly revenue $387.7M, up 7.0% YoY from $362.3M
  • Operating margin 10.3% vs 9.1% YoY, gross margin 32.1% vs 32.2%
  • Best segment personal care: revenue $301.0M, up 9.2%, operating margin 19.9% vs 18.5%
  • Worst segment hospice: operating margin 22.0% vs 27.3%, revenue $69.0M, up 0.2%
  • Cash $98.5M, operating cash flow $133.3M, $100.0M revolving debt repayment, AccentCare acquisition anticipated at approximately $275.0M
  • Near-term headwinds: caregiver shortages, inflation, elevated interest rates, Medicaid spending reductions, home health payments estimated down 1.3% in 2026

AI summary of the ADUS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 3, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results for the quarter ended September 30, 2026 announced
  • Press release issued November 3, 2026, with financial details in Exhibit 99.1

Item 7.01: Regulation FD Disclosure

  • Q3 2026 results announced for quarter ended September 30, 2026
  • Investor-relevant operating and financial metrics contained in Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q3 revenue $387.7M, up 7.0%, with net income $28.6M and diluted EPS $1.54
  • Adjusted EBITDA $51.2M, up 13.5%, and adjusted diluted EPS $1.83, up 17.3%
Filed Sep 14, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • $275 million cash acquisition of AccentCare’s personal and community care business outside New York
  • Scope includes 10 operating entities plus selected Colorado assets and liabilities

Item 7.01: Regulation FD Disclosure

  • September 14, 2026 press release announced Addus HomeCare’s entry into a Purchase Agreement
  • Purchase Agreement details are provided in furnished Exhibit 99.1
Filed Aug 13, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • President and COO Heather Dixon departed Addus HomeCare on August 7, 2026
  • Former COO W. Bradley Bickham appointed interim COO, providing experienced internal leadership

Item 7.01: Regulation FD Disclosure

  • August 10, 2026 press release announces matters described under Item 5.02
  • Investor focus: leadership or director changes and potential succession implications disclosed in Exhibit 99.1

AI summaries of ADUS 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ADUS

Don't miss the next ADUS filing

  • Alerts as it files. A push when ADUS files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ADUS, by share count.
  • Ask anything. An AI agent that reads every ADUS filing and answers with sources.

ADUS alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Weaver Susan TGNov 12, 2026-
Anderson DarbyMNov 10, 2026$34.05
BLESSING CLIFF DONALDSellNov 10, 2026$123.10
BLESSING CLIFF DONALDSellNov 10, 2026$124.18
Anderson DarbySellNov 10, 2026$123.41
BLESSING CLIFF DONALDSellNov 10, 2026$124.62
Anderson DarbySellNov 10, 2026$122.30
Anderson DarbyMNov 10, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$1.2B$1.4B
Gross Profit-$375.0M$461.9M
Operating Income-$102.7M$138.6M
Net Income-$73.6M$95.9M
Gross Margin-32.5%32.5%
Op. Margin-8.9%9.7%
Net Margin-6.4%6.7%
Balance Sheet
Total Assets$1.0B$1.4B$1.4B
Equity$706.7M$970.5M$1.1B
ROE-7.6%8.8%
Per Share
EPS-$4.23$5.22
Cash Flow
Operating CF-$116.4M$111.5M
CapEx-$6.0M$7.7M

Source: XBRL data in Addus HomeCare Corp (ADUS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ADUS share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ADUS shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202631$992.3M
Q2 202631$961.5M
Q1 202634$865.3M
Q4 202529$984.6M
Q3 202529$1.08B
Q2 202530$1.02B
Q1 202526$572.4M
Q4 202425$577.8M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 235 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ADUS filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 16, 2026--
4Nov 12, 2026--
4Nov 12, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
10-QNov 4, 2026Analysis
8-KNov 3, 2026Analysis-
8-KSep 14, 2026Analysis-
8-KAug 13, 2026Analysis-
10-QAug 4, 2026Analysis
8-KAug 3, 2026Analysis-
4Jun 23, 2026--
4Jun 11, 2026--
4Jun 11, 2026--
4Jun 11, 2026--
4Jun 11, 2026--
4Jun 11, 2026--
4Jun 11, 2026--
4Jun 11, 2026--
8-KJun 10, 2026Analysis
4May 22, 2026-

Related Health Care companies

All Health Care →

ADUS SEC filings: frequently asked questions

Are ADUS insiders buying or selling?

In the last 90 days, Addus HomeCare Corp (ADUS) officers, directors and 10% owners reported no open-market purchases and 22 open-market sales worth $17.5 million by 7 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold ADUS stock?

As of September 30, 2026, the largest Addus HomeCare Corp (ADUS) holders among the 13F filers tracked by SignalX were BlackRock ($376.8 million), Dimensional Fund Advisors ($101.2 million), State Street Corp ($87.6 million), Vanguard Capital Management LLC ($87.3 million), Principal Financial Group ($46.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ADUS's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Addus HomeCare Corp (ADUS) reported revenue of $1.4 billion (up 23.2% from FY2024) and net income of $95.9 million. Diluted EPS was $5.22. The figures come from the XBRL data in the 10-K.

What are the main risks in ADUS's latest 10-K?

In the 10-K filed February 24, 2026, Addus HomeCare Corp (ADUS) flagged: Variable interest rates on $124.3 million revolving loan with $8.5 million interest payable within 12 months at 5.48% as of January 2026. Inflation-driven wage increases impacting caregiver labor costs amid tight labor market and limited fee rate increases from government programs. (AI summary of the Risk Factors section.)

What did ADUS report in its latest 8-K?

Addus HomeCare Corp (ADUS) filed an 8-K on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 2026 results for the quarter ended September 30, 2026 announced.

What are the latest ADUS SEC filings?

Addus HomeCare Corp (ADUS) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on November 16, 2026.

What is ADUS's SEC CIK number?

Addus HomeCare Corp (ADUS)'s SEC Central Index Key (CIK) is 1468328. EDGAR lists every ADUS filing under that number.

Ask anything about ADUS

The research agent reads ADUS's filings, financials, insider trades and 13F holders, then answers with sources.